Yale University

Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.

TitleDrug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone.
Publication TypeJournal Article
Year of Publication2011
AuthorsFiellin, David A., Linda Weiss, Michael Botsko, James E. Egan, Frederick L. Altice, Lauri B. Bazerman, Amina Chaudhry, Chinazo O. Cunningham, Marc N. Gourevitch, Paula J. Lum, Lynn E. Sullivan, Richard S. Schottenfeld, and Patrick G. O'Connor
Corporate AuthorsBHIVES Collaborative
JournalJournal of acquired immune deficiency syndromes (1999)
Volume56 Suppl 1
PaginationS33-8
Date Published2011 Mar
ISSN1944-7884
KeywordsBuprenorphine, Female, HIV Infections, Humans, Male, Naloxone, Narcotic Antagonists, Odds Ratio, Opiate Substitution Treatment, Opioid-Related Disorders, Prospective Studies, Treatment Outcome
AbstractBuprenorphine/naloxone allows the integration of opioid dependence and HIV treatment.
DOI10.1097/QAI.0b013e3182097537
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links